Use Cord Blood Single Nucleotide Polymorphism to Predict the Later Development of Atopy and Allergy

NCT ID: NCT00444327

Last Updated: 2009-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

900 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our study was firstly to detect in cord bloods the polymorphism of genes related to atopy and allergic diseases and to examine their mutual interaction and their associations with cord blood IgE and cytokines. After that, in the prospective follow-up visits, we liked to investigate if the measurement of cord blood SNPs of genes related to atopy and allergic diseases was helpful in predicting the development of atopy and allergic diseases later in life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopy Allergic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Apgar score of 5 minutes not less than 7 gestational age not less than 36 weeks

Exclusion Criteria

* Apgar score of 5 minutes \< 7 gestational age \< 36 weeks
Maximum Eligible Age

1 Minute

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role collaborator

Min-Sheng General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Min-Sheng General Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chien-Han Chen, M.D.

Role: PRINCIPAL_INVESTIGATOR

Min-Sheng General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Min-Sheng General Hospital

Taoyuan District, , Taiwan

Site Status NOT_YET_RECRUITING

Min-Sheng General Hospital

Taoyuan District, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chien-Han Chen, M.D.

Role: CONTACT

886-3-3179599 ext. 2007

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2007005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cohort of Cord Blood Bank
NCT07249099 ENROLLING_BY_INVITATION